{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:47:29Z","timestamp":1792223249855,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Post Kala-azar dermal leishmaniasis (PKDL), caused by <jats:italic>Leishmania donovani<\/jats:italic> is the dermal sequel of Visceral Leishmaniasis and importantly, is the proposed disease reservoir. The survival of <jats:italic>Leishmania<\/jats:italic> parasites within monocytes\/macrophages hinges on its ability to effectively nullify immune activation mechanisms. Thus, delineating the disease-promoting immune mechanisms can facilitate development of immunotherapeutic strategies. Accordingly, in the absence of an animal model, this study aimed to delineate the status of CD8<jats:sup>+<\/jats:sup> T-cells in patients with PKDL. At disease presentation, the absence of CD4<jats:sup>+<\/jats:sup> T-cells at lesional sites was concomitant with an overwhelming infiltration of CD8<jats:sup>+<\/jats:sup> T-cells that demonstrated an absence of Perforin, Granzyme and Zap-70, along with an enhanced expression of Programmed Death-1 (PD-1) and the skin-homing CCL17. Additionally, the lesional CCR4<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> population was associated with an enhanced expression of IL-10 and IL-5. In circulation, the enhanced CD8<jats:sup>+<\/jats:sup>CCR4<jats:sup>+<\/jats:sup> T-cell population and raised levels of CCL17\/22 was associated with an increased frequency of PD-1, while CD127 was decreased. Taken together, in PKDL, the enhanced plasma and lesional CCL17 accounted for the dermal homing of CD8<jats:sup>+<\/jats:sup>CCR4<jats:sup>+<\/jats:sup> T-cells, that along with a concomitant upregulation of PD-1 and IL-10 mediated immune inactivation, emphasizing the need for designing immunotherapies capable of reinvigorating T-cell potency.<\/jats:p>","DOI":"10.1038\/s41598-018-37144-y","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:04:17Z","timestamp":1548327857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Impaired activation of lesional CD8+ T-cells is associated with enhanced expression of Programmed Death-1 in Indian Post Kala-azar Dermal Leishmaniasis"],"prefix":"10.1038","volume":"9","author":[{"given":"Shibabrata","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjan","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay","family":"Kanti Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uttara","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"von Stebut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitali","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"37144_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1365-4632.2010.04558.x","volume":"49","author":"S Ganguly","year":"2010","unstructured":"Ganguly, S., Das, N. K., Barbhuiya, J. N. & Chatterjee, M. Post-kala-azar dermal leishmaniasis-an overview. Int J Dermatol 49, 921\u2013931 (2010).","journal-title":"Int J Dermatol"},{"key":"37144_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","volume":"3","author":"EE Zijlstra","year":"2003","unstructured":"Zijlstra, E. E., Musa, A. M., Khalil, E. A., el-Hassan, I. M. & el-Hassan, A. M. Post kala-azar dermal leishmaniasis. Lancet Infect Dis 3, 87\u201398 (2003).","journal-title":"Lancet Infect Dis"},{"key":"37144_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-2424-8","volume":"15","author":"V Ramesh","year":"2015","unstructured":"Ramesh, V., Kaushal, H., Mishra, A. K., Singh, R. & Salotra, P. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study. BMC Public Health 15, 1092 (2015).","journal-title":"BMC Public Health"},{"key":"37144_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1365-2133.2000.03603.x","volume":"143","author":"EE Zijlstra","year":"2000","unstructured":"Zijlstra, E. E., Khalil, E. A., Kager, P. A. & El-Hassan, A. M. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol 143, 136\u2013143 (2000).","journal-title":"Br J Dermatol"},{"key":"37144_CR5","first-page":"802","volume":"96","author":"SK Bhattacharya","year":"2017","unstructured":"Bhattacharya, S. K. & Dash, A. P. Elimination of Kala-Azar from the Southeast Asia Region. Am J Trop Med Hyg 96, 802\u2013804 (2017).","journal-title":"Am J Trop Med Hyg"},{"key":"37144_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1473-3099(16)30140-2","volume":"16","author":"OP Singh","year":"2017","unstructured":"Singh, O. P., Hasker, E., Boelaert, M. & Sundar, S. Elimination of visceral leishmaniasis on the Indian subcontinent. Lancet Infect Dis 16, 304\u2013309 (2017).","journal-title":"Lancet Infect Dis"},{"key":"37144_CR7","doi-asserted-by":"publisher","first-page":"e0005877","DOI":"10.1371\/journal.pntd.0005877","volume":"11","author":"EE Zijlstra","year":"2017","unstructured":"Zijlstra, E. E., Alves, F., Rijal, S., Arana, B. & Alvar, J. Post-kala-azar dermal Leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme. PLoS Negl Trop Dis 11, e0005877 (2017).","journal-title":"PLoS Negl Trop Dis"},{"key":"37144_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","volume":"30","author":"D Mukhopadhyay","year":"2014","unstructured":"Mukhopadhyay, D., Dalton, J. E., Kaye, P. M. & Chatterjee, M. Post kala-azar dermal leishmaniasis: an unresolved mystery. Trends Parasitol 30, 65\u201374 (2014).","journal-title":"Trends Parasitol"},{"key":"37144_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.pt.2014.05.006","volume":"30","author":"MA Hartley","year":"2014","unstructured":"Hartley, M. A., Drexler, S., Ronet, C., Beverley, S. M. & Fasel, N. The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis. Trends Parasitol 30, 412\u2013422 (2014).","journal-title":"Trends Parasitol"},{"key":"37144_CR10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00018-013-1491-1","volume":"71","author":"DM Walker","year":"2014","unstructured":"Walker, D. M. et al. Mechanisms of cellular invasion by intracellular parasites. Cell Mol Life Sci 71, 1245\u20131263 (2014).","journal-title":"Cell Mol Life Sci"},{"key":"37144_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","volume":"9","author":"P Kaye","year":"2011","unstructured":"Kaye, P. & Scott, P. Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol 9, 604\u2013615 (2011).","journal-title":"Nat Rev Microbiol"},{"key":"37144_CR12","first-page":"251","volume":"3","author":"R Kumar","year":"2012","unstructured":"Kumar, R. & Nyl\u00e9n, S. Immunobiology of visceral leishmaniasis. Front Immunol 3, 251 (2012).","journal-title":"Front Immunol"},{"key":"37144_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10875-014-0115-3","volume":"35","author":"S Roy","year":"2015","unstructured":"Roy, S. et al. A defective oxidative burst and impaired antigen presentation are hallmarks of human Visceral Leishmaniasis. J Clin Immunol 35, 56\u201367 (2015).","journal-title":"J Clin Immunol"},{"key":"37144_CR14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/iai.61.3.1069-1073.1993","volume":"61","author":"M Kemp","year":"1993","unstructured":"Kemp, M. et al. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 61, 1069\u20131073 (1993).","journal-title":"Infect Immun"},{"key":"37144_CR15","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1086\/588387","volume":"197","author":"S Ganguly","year":"2008","unstructured":"Ganguly, S. et al. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis. J Infect Dis 197, 1762\u20131771 (2008).","journal-title":"J Infect Dis"},{"key":"37144_CR16","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/infdis\/jir551","volume":"204","author":"D Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay, D. et al. Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis. J Infect Dis 204, 1427\u20131436 (2011).","journal-title":"J Infect Dis"},{"key":"37144_CR17","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.1371\/journal.pntd.0001171","volume":"5","author":"GK Katara","year":"2011","unstructured":"Katara, G. K., Ansari, N. A., Verma, S., Ramesh, V. & Salotra, P. Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients. PLoS Negl Trop Dis 5, e1171 (2011).","journal-title":"PLoS Negl Trop Dis"},{"key":"37144_CR18","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","volume":"8","author":"S Saha","year":"2007","unstructured":"Saha, S. et al. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol 8, 5592\u20135603 (2007).","journal-title":"J Immunol"},{"key":"37144_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1086\/506624","volume":"194","author":"NA Ansari","year":"2006","unstructured":"Ansari, N. A., Ramesh, V. & Salotra, P. Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis 194, 958\u2013965 (2006).","journal-title":"J Infect Dis"},{"key":"37144_CR20","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/jid.2009.393","volume":"130","author":"S Ganguly","year":"2010","unstructured":"Ganguly, S. et al. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian Post-kala-azar dermal leishmaniasis. J Invest Dermatol 130, 1013\u20131022 (2010).","journal-title":"J Invest Dermatol"},{"key":"37144_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/exd.12635","volume":"24","author":"S Mukherjee","year":"2015","unstructured":"Mukherjee, S. et al. Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis. Exp Dermatol 24, 232\u2013234 (2015).","journal-title":"Exp Dermatol"},{"key":"37144_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10875-015-0215-8","volume":"36","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee, S. et al. Decreased presence and secretion of CD26 promotes disease progression in Indian Post kala-azar dermal leishmaniasis. J Clin Immunol 36, 85\u201394 (2016).","journal-title":"J Clin Immunol"},{"key":"37144_CR23","doi-asserted-by":"publisher","first-page":"e0004145","DOI":"10.1371\/journal.pntd.0004145","volume":"9","author":"D Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay, D. et al. M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis. PLoS Negl Trop Dis 9, e0004145 (2015).","journal-title":"PLoS Negl Trop Dis"},{"key":"37144_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/cei.12787","volume":"185","author":"H Kaushal","year":"2016","unstructured":"Kaushal, H. et al. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India. Clin Exp Immunol 185, 50\u201360 (2016).","journal-title":"Clin Exp Immunol"},{"key":"37144_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/cid\/cix808","volume":"66","author":"S Moulik","year":"2018","unstructured":"Moulik, S. et al. Monitoring of parasite kinetics in Indian Post Kala Azar Dermal Leishmaniasis. Clin Infect Dis 66, 404\u2013410 (2018).","journal-title":"Clin Infect Dis"},{"key":"37144_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/ijd.13048","volume":"55","author":"D Mukhopadhyay","year":"2016","unstructured":"Mukhopadhyay, D. et al. A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone. Int J Dermatol 55, 250\u2013255 (2016).","journal-title":"Int J Dermatol"},{"key":"37144_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/1755-6783.149508","volume":"7","author":"S DasGupta","year":"2014","unstructured":"DasGupta, S., Mukherjee, S., Das, R. N., Chatterjee, U. & Chatterjee, M. Perineurial infiltration: Not always leprosy. Ann Trop Med Public Health 7, 195\u2013196 (2014).","journal-title":"Ann Trop Med Public Health"},{"key":"37144_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-4632.2004.01579.x","volume":"44","author":"SK Rathi","year":"2005","unstructured":"Rathi, S. K., Pandhi, R. K., Chopra, P. & Khanna, N. Lesional T-cell subset in post-kala-azar dermal leishmaniasis. Int J Dermatol 44, 12\u201313 (2005).","journal-title":"Int J Dermatol"},{"key":"37144_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/23495","volume":"6746","author":"JJ Campbell","year":"1999","unstructured":"Campbell, J. J. et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 6746, 776\u2013780 (1999).","journal-title":"Nature"},{"key":"37144_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith, J. W., Sokol, C. L. & Luster, A. D. Chemokines and chemokine receptors: positioning cells for host defence and immunity. Annu Rev Immunol 32, 659\u2013702 (2014).","journal-title":"Annu Rev Immunol"},{"key":"37144_CR31","doi-asserted-by":"publisher","first-page":"a002279","DOI":"10.1101\/cshperspect.a002279","volume":"2","author":"H Wang","year":"2010","unstructured":"Wang, H. et al. ZAP-70: an essential kinase in T-cell signaling. Cold Spring Harb Perspect Biol 2, a002279 (2010).","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"37144_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1009","volume":"4","author":"SM Kaech","year":"2003","unstructured":"Kaech, S. M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4, 1191\u20131198 (2003).","journal-title":"Nat Immunol"},{"key":"37144_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/ni.2687","volume":"14","author":"PM Gubser","year":"2013","unstructured":"Gubser, P. M. et al. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat Immunol 14, 1064\u20131072 (2013).","journal-title":"Nat Immunol"},{"key":"37144_CR34","doi-asserted-by":"publisher","first-page":"14664","DOI":"10.1038\/s41598-017-15288-7","volume":"7","author":"A Dayakar","year":"2017","unstructured":"Dayakar, A., Chandrasekaran, S., Veronica, J., Bharadwaja, V. & Maurya, R. Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB\/c Mice. Sc Rep 7, 14664 (2017).","journal-title":"Sc Rep"},{"key":"37144_CR35","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","volume":"32","author":"L Carter","year":"2002","unstructured":"Carter, L. et al. PD-1: PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32, 634\u2013643 (2002).","journal-title":"Eur J Immunol"},{"key":"37144_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"37144_CR37","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/rheumatology\/kes171","volume":"51","author":"B Jakiela","year":"2012","unstructured":"Jakiela, B. et al. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients. Rheumatology (Oxford) 51, 1887\u20131893 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"37144_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","volume":"2","author":"N Zhang","year":"2011","unstructured":"Zhang, N. & Bevan, M. J. CD8(+) T cells: foot soldiers of the immune system. Immunity 2, 161\u2013168 (2011).","journal-title":"Immunity"},{"key":"37144_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00281-015-0475-7","volume":"37","author":"FO Novais","year":"2015","unstructured":"Novais, F. O. & Scott, P. CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly. Semin Immunopathol 37, 251\u2013259 (2015).","journal-title":"Semin Immunopathol"},{"key":"37144_CR40","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1365-2133.2009.09573.x","volume":"162","author":"B Geiger","year":"2010","unstructured":"Geiger, B., Wenzel, J. & Hantschke, M. Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1\/T cytotoxic type 1 cells. Br J Dermatol 162, 870\u2013874 (2010).","journal-title":"Br J Dermatol"},{"key":"37144_CR41","doi-asserted-by":"publisher","first-page":"e1006196","DOI":"10.1371\/journal.ppat.1006196","volume":"13","author":"FO Novais","year":"2017","unstructured":"Novais, F. O. et al. CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1\u03b2 production. PLoS Pathog 13, e1006196 (2017).","journal-title":"PLoS Pathog"},{"key":"37144_CR42","doi-asserted-by":"publisher","first-page":"e1006349","DOI":"10.1371\/journal.ppat.1006349","volume":"13","author":"ND Glennie","year":"2017","unstructured":"Glennie, N. D., Volk, S. W. & Scott, P. Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes. PLoS Pathog 13, e1006349 (2017).","journal-title":"PLoS Pathog"},{"key":"37144_CR43","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1371\/journal.pntd.0000871","volume":"4","author":"J Hern\u00e1ndez-Ruiz","year":"2010","unstructured":"Hern\u00e1ndez-Ruiz, J. et al. CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists. PLoS Negl Trop Dis 4, e871 (2010).","journal-title":"PLoS Negl Trop Dis"},{"key":"37144_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1600-0560.2006.00531.x","volume":"33","author":"A Ismail","year":"2006","unstructured":"Ismail, A., Gadir, A. F., Theander, T. G., Kharazmi, A. & El Hassan, A. M. Pathology of post-kala-azar dermal leishmaniasis: a light microscopical, immunohistochemical, and ultrastructural study of skin lesions and draining lymph nodes. J Cutan Pathol 33, 78\u201387 (2006).","journal-title":"J Cutan Pathol"},{"key":"37144_CR45","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1182\/blood-2010-02-271981","volume":"116","author":"S Huber","year":"2010","unstructured":"Huber, S., Hoffmann, R., Muskens, F. & Voehringer, D. Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood 116, 3311\u20133320 (2010).","journal-title":"Blood"},{"key":"37144_CR46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1084\/jem.185.1.55","volume":"185","author":"AD Badley","year":"1997","unstructured":"Badley, A. D. et al. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 185, 55\u201364 (1997).","journal-title":"J Exp Med"},{"key":"37144_CR47","doi-asserted-by":"publisher","first-page":"e0004911","DOI":"10.1371\/journal.pntd.0004911","volume":"10","author":"CT Prendergast","year":"2016","unstructured":"Prendergast, C. T., Sanin, D. E. & Mountford, A. P. Alternatively Activated Mononuclear Phagocytes from the Skin Site of Infection and the Impact of IL-4R\u03b1 Signalling on CD4+ T Cell Survival in Draining Lymph Nodes after Repeated Exposure to Schistosoma mansoni Cercariae. PLoS Negl Trop Dis 10, e0004911 (2016).","journal-title":"PLoS Negl Trop Dis"},{"key":"37144_CR48","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.4049\/jimmunol.1202722","volume":"190","author":"JC Cyktor","year":"2013","unstructured":"Cyktor, J. C. et al. IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection. J Immunol 190, 2778\u20132790 (2013).","journal-title":"J Immunol"},{"key":"37144_CR49","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.humimm.2010.09.002","volume":"71","author":"AP Campanelli","year":"2010","unstructured":"Campanelli, A. P. et al. Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis. Hum Immunol 71, 1220\u20131227 (2010).","journal-title":"Hum Immunol"},{"key":"37144_CR50","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","volume":"119","author":"K Ferenczi","year":"2002","unstructured":"Ferenczi, K., Fuhlbrigge, R. C., Pinkus, J., Pinkus, G. S. & Kupper, T. S. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119, 1405\u20131410 (2002).","journal-title":"J Invest Dermatol"},{"key":"37144_CR51","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nm.4023","volume":"22","author":"F Dotiwala","year":"2016","unstructured":"Dotiwala, F. et al. Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites. Nat Med 22, 210\u2013216 (2016).","journal-title":"Nat Med"},{"key":"37144_CR52","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/JVI.02021-06","volume":"81","author":"H Radziewicz","year":"2007","unstructured":"Radziewicz, H. et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol. 81, 2545\u20132553 (2007).","journal-title":"J Virol."},{"key":"37144_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/85330","volume":"2","author":"Y Latchman","year":"2001","unstructured":"Latchman, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2, 261\u2013268 (2001).","journal-title":"Nat Immunol"},{"key":"37144_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pt.2012.07.001","volume":"28","author":"JP Gigley","year":"2012","unstructured":"Gigley, J. P., Bhadra, R., Moretto, M. M. & Khan, I. A. T cell exhaustion in protozoan disease. Trends Parasitol 28, 377\u2013384 (2012).","journal-title":"Trends Parasitol"},{"key":"37144_CR55","doi-asserted-by":"publisher","first-page":"e1000431","DOI":"10.1371\/journal.ppat.1000431","volume":"5","author":"T Joshi","year":"2009","unstructured":"Joshi, T., Rodriguez, S., Perovic, V., Cockburn, I. A. & St\u00e4ger, S. B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections. PLoS Pathog 5, e1000431 (2009).","journal-title":"PLoS Pathog"},{"key":"37144_CR56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/infdis\/jit401","volume":"209","author":"S Gautam","year":"2014","unstructured":"Gautam, S. et al. CD8 T-cell exhaustion in human visceral leishmaniasis. J Infect Dis 209, 290\u2013299 (2014).","journal-title":"J Infect Dis"},{"key":"37144_CR57","doi-asserted-by":"publisher","first-page":"688","DOI":"10.4269\/ajtmh.2011.10-0590","volume":"84","author":"NK Das","year":"2011","unstructured":"Das, N. K. et al. Case series of misdiagnosis with rK39 strip test in Indian leishmaniasis. Am J Trop Med Hyg 84, 688\u2013691 (2011).","journal-title":"Am J Trop Med Hyg"}],"updated-by":[{"DOI":"10.1038\/s41598-019-48640-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37144-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37144-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:10:08Z","timestamp":1671253808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37144-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37144"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37144-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-019-48640-0","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"23 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"762"}}